{
    "eid": "2-s2.0-85096187432",
    "title": "Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term Vitamin K antagonist treatment to dabigatran",
    "cover-date": "2020-11-12",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "anticoagulation",
        "atrial fibrillation",
        "oral anticoagulants",
        "quality of care and outcomes",
        "stroke"
    ],
    "authors": [
        "Eue Keun Choi",
        "Young Soo Lee",
        "Alan Koay Choon Chern",
        "Panyapat Jiampo",
        "Aurauma Chutinet",
        "Dicky Armein Hanafy",
        "Prabhav Trivedi",
        "Dongmei Zhai",
        "Yong Seog Oh"
    ],
    "citedby-count": 4,
    "ref-count": 35,
    "ref-list": [
        "Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population",
        "Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-Vitamin K antagonist oral anticoagulants: A nationwide population-based study",
        "Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: A report from the Taiwan nationwide AF cohort study",
        "Predicting atrial fibrillation and its complications",
        "Stroke prevention in atrial fibrillation: Focus on Asian patients",
        "Racial/Ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation",
        "Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation",
        "Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?",
        "Dabigatran versus warfarin in patients with atrial fibrillation",
        "Rivaroxaban versus warfarin in nonvalvular atrial fibrillation",
        "Apixaban versus warfarin in patients with atrial fibrillation",
        "Edoxaban versus warfarin in patients with atrial fibrillation",
        "Effectiveness and safety of contemporary oral anticoagulants among Asians with nonvalvular atrial fibrillation",
        "Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients",
        "The safety of NOACs in atrial fibrillation patient subgroups: A narrative review",
        "2018 Korean guideline of atrial fibrillation management",
        "2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task force on clinical practice guidelines and the heart rhythm Society",
        "2017 consensus of the Asia Pacific heart rhythm Society on stroke prevention in atrial fibrillation",
        "2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association",
        "Non-Vitamin K antagonist oral anticoagulation agents in anticoagulant na\u00efve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013",
        "2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS",
        "Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: The 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q)",
        "Scoring and psychometric validation of the perception of anticoagulant treatment questionnaire (PACT-Q)",
        "Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry",
        "The changing landscape for stroke prevention in AF: Findings from the GLORIA-AF registry phase 2",
        "Quality of life and patient satisfaction in patients with atrial fibrillation on stable Vitamin K antagonist treatment or switched to a non-Vitamin K antagonist oral anticoagulant during a 1-year follow-up: A prefer in AF registry substudy",
        "Stroke prevention in atrial fibrillation: Concepts and controversies",
        "Quality of Inr control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K antagonists in Spain. A population-based, real-world study",
        "Non-Vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal",
        "Shifting to a non-Vitamin K antagonist oral anticoagulation agent from Vitamin K antagonist in atrial fibrillation",
        "The importance of time in therapeutic range in switching from Vitamin K antagonist to non-Vitamin K antagonist oral anticoagulants in atrial fibrillation",
        "Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: Results from the outcomes Registry for better informed treatment of atrial fibrillation",
        "NOACs replace VKA as preferred oral anticoagulant among new patients: A drug utilization study in 560 pharmacies in the Netherlands",
        "Stroke in atrial fibrillation: Review of risk stratification and preventive therapy",
        "Post-hoc data analysis: Benefits and limitations"
    ],
    "affiliation": [
        {
            "affiliation-city": "Ridgefield",
            "@id": "60105084",
            "affilname": "Boehringer Ingelheim Pharmaceuticals, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60105084",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "West Jakarta",
            "@id": "60070444",
            "affilname": "Pusat Jantung Nasional Harapan Kita",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60070444",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": null,
            "@id": "60022738",
            "affilname": "Bhumibol Adulyadej Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022738",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60021145",
            "affilname": "Institut Jantung Negara Kuala Lumpur",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021145",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60021119",
            "affilname": "Seoul National University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021119",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Gyeongsan",
            "@id": "60013400",
            "affilname": "Catholic University of Daegu",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013400",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Ingelheim am Rhein",
            "@id": "60011807",
            "affilname": "Boehringer Ingelheim Pharma GmbH &amp; Co. KG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011807",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Bucheon-si",
            "@id": "60003087",
            "affilname": "The Catholic University of Korea",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003087",
            "affiliation-country": "South Korea"
        }
    ],
    "funding": [
        "MarksMan Healthcare Communications",
        "Boehringer Ingelheim"
    ]
}